Patent
   D454194
Priority
Jan 23 2001
Filed
Jan 23 2001
Issued
Mar 05 2002
Expiry
Mar 05 2016
Assg.orig
Entity
unknown
16
3
n/a
The ornamental design for a drug reconstitution and injection device, as shown and described.

FIG. 1 is a perspective view of a drug reconstitution and injection device showing my new design;

FIG. 2 is a front view thereof;

FIG. 3 is a left side view thereof;

FIG. 4 is a right side view thereof;

FIG. 5 is a rear view thereof;

FIG. 6 is a top view thereof; and,

FIG. 7 is a bottom view thereof.

Bar-Or, Jonathan

Patent Priority Assignee Title
D469865, Jan 23 2001 Elan Pharma International Limited Multi-vial drug reconstitution and injection device
D530009, Mar 15 2004 Amgen Inc Syringe tool
D530817, Mar 15 2004 Amgen Inc. Syringe tool
D625805, Oct 27 2009 Needle guide
D690411, Jul 27 2011 DUOJECT MEDICAL SYSTEMS INC Reconstitution device
D692552, Nov 08 2011 Becton Dickinson France Microinfuser
D692997, Nov 08 2011 Becton Dickinson France Microinfuser
D693455, Nov 08 2011 Becton, Dickinson and Company Microinfuser
D711527, Nov 08 2011 Becton, Dickinson and Company Microinfuser
D767120, Jul 30 2015 BECTON, DICKINSON COMPANY; Becton, Dickinson and Company Medical injector
D774640, Jul 30 2015 Becton, Dickinson and Company Medical injector
D776262, Jul 30 2015 Becton, Dickinson and Company Medical injector
D776263, Jul 30 2015 Becton, Dickinson and Company Medical injector
D776264, Jul 30 2015 Becton, Dickinson and Company Medical injector
D776265, Jul 30 2015 Becton, Dickinson and Company Medical injector
D794776, Jul 30 2015 Becton, Dickinson and Company Medical injector
Patent Priority Assignee Title
5566729, Apr 06 1995 HOSPIRA, INC Drug reconstitution and administration system
6258063, Jan 17 1997 Roche Diagnostics GmbH Hypodermic injection system
D437930, May 13 1999 Elan Corporation, PLC Drug conversion device
///////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 13 2000BAR-OR, JONATHANElan Pharma International LimitedASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0115320906 pdf
Jan 23 2001Elan Pharma International Limited(assignment on the face of the patent)
Sep 16 2011Alkermes Pharma Ireland LimitedMORGAN STANLEY SENIOR FUNDING, INC PATENT SECURITY AGREEMENT SECOND LIEN 0269940245 pdf
Sep 16 2011ALKERMES, INC MORGAN STANLEY SENIOR FUNDING, INC PATENT SECURITY AGREEMENT SECOND LIEN 0269940245 pdf
Sep 16 2011ALKERMES CONTROLLED THERAPEUTICS INC MORGAN STANLEY SENIOR FUNDING, INC PATENT SECURITY AGREEMENT FIRST LIEN 0269940186 pdf
Sep 16 2011Alkermes Pharma Ireland LimitedMORGAN STANLEY SENIOR FUNDING, INC PATENT SECURITY AGREEMENT FIRST LIEN 0269940186 pdf
Sep 16 2011ALKERMES, INC MORGAN STANLEY SENIOR FUNDING, INC PATENT SECURITY AGREEMENT FIRST LIEN 0269940186 pdf
Sep 16 2011ALKERMES CONTROLLED THERAPEUTICS INC MORGAN STANLEY SENIOR FUNDING, INC PATENT SECURITY AGREEMENT SECOND LIEN 0269940245 pdf
Sep 24 2012MORGAN STANLEY SENIOR FUNDING, INC ALKERMES CONTROLLED THERAPEUTICS INC RELEASE BY SECURED PARTY SECOND LIEN 0291160379 pdf
Sep 24 2012MORGAN STANLEY SENIOR FUNDING, INC Alkermes Pharma Ireland LimitedRELEASE BY SECURED PARTY SECOND LIEN 0291160379 pdf
Sep 24 2012MORGAN STANLEY SENIOR FUNDING, INC ALKERMES, INC RELEASE BY SECURED PARTY SECOND LIEN 0291160379 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule